Centre confirms presence of Mpox virus in isolated patient, no
New Delhi, Sep 9 (IANS) The Centre on Monday said the suspected case of monkeypox (Mpox) has been verified in a patient as a travel-related infection, adding that there is no widespread risk to the public at this time. The Ministry of Health and Family Welfare said that laboratory testing has confirmed the presence of
601. Centre confirms presence of Mpox virus in isolated patient, no widespread risk
New Delhi, Sep 9 (IANS) The Centre on Monday said the suspected case of monkeypox (Mpox) has been verified in a patient as a travel-related infection, adding that there is no widespread risk to the public at this time.
The Ministry of Health and Family Welfare said that laboratory testing has confirmed the presence of the Mpox virus of the West African ‘clade 2’ in the patient.
This case is an isolated case, similar to the earlier 30 cases reported in India from July 2022 onwards, and is not a part of the current public health emergency (reported by WHO) which is regarding clade 1 of mpox, the ministry clarified.
“The individual, a young male who recently travelled from a country experiencing ongoing Mpox transmission, is currently isolated at a designated tertiary care isolation facility. The patient remains clinically stable and is without any systemic illness or comorbidities,” it clarified.
The case aligns with earlier risk assessments and continues to be managed according to established protocols. Public health measures, including contact tracing and monitoring, are actively in place to ensure the situation is contained.
“There is no indication of any widespread risk to the public at this time,” said the government.
Health experts have advised not to panic as the monkeypox virus has minimal pandemic potential.
“There is no need to panic. While fatality remains high, transmission is possible only among close contacts,” Dr. Harshal R. Salve, Additional professor, Centre for Community Medicine at AIIMS, New Delhi, told IANS.
Mpox is a viral disease identified as fever, rash, and lymphadenopathy — a condition that causes lymph nodes to swell or become abnormally shaped or sized. It is a self-limiting disease and patients recover within 4 weeks, Salve said.
The Centre has advised the states and union territories to screen, test, and trace contacts of all suspected Mpox cases.
–IANS
na/vd
ସମ୍ବଲପୁରରେ ସି.ଏମ କିଷାନ ସହାୟତା ଯୋଜନାର ଶୁଭାରମ୍ଭ କଲେ ମୁଖ୍ୟମନ୍ତ୍ରୀ
Next Articleଶ୍ରୀମନ୍ଦିରରେ ଋଷି ପଞ୍ଚମୀ ନୀତି ସମ୍ପର୍ଣ୍ଣ
Related Articles
New AI tool to revolutionise personalised cancer treatment

ସ୍ୱାସ୍ଥ୍ୟ ଓ ଜୀବନଶୈଳୀNew AI tool to revolutionise personalised cancer treatment
New Delhi: An international team of scientists has developed an artificial intelligence (AI) tool that could revolutionise cancer treatment by mapping cellular diversity within tumours. The innovation tackles tumour heterogeneity in oncology, where varied cell populations cause treatment resistance and recurrence, Xinhua news agency reported. The AAnet AI tool, developed by the Sydney-based Garvan Institute
Covid-19 virus protein triggers immune attack on healthy cells: Study

ସ୍ୱାସ୍ଥ୍ୟ ଓ ଜୀବନଶୈଳୀCovid-19 virus protein triggers immune attack on healthy cells: Study
New Delhi: Amid a fresh wave of Covid-19, Israeli researchers have discovered that a protein from the SARS-CoV-2 virus can cause the immune system to attack healthy cells mistakenly. The study, published in the journal Cell Reports, sheds light on how severe Covid complications may occur and suggests new ways to prevent immune-driven damage from
Global AI collaboration revolutionises personalised cancer treatment

ସ୍ୱାସ୍ଥ୍ୟ ଓ ଜୀବନଶୈଳୀGlobal AI collaboration revolutionises personalised cancer treatment
New Delhi: An international team of scientists has unveiled an artificial intelligence (AI) technique that securely analyses global cancer samples, paving the way for more personalised and privacy-protected cancer treatments. This innovative approach promises to accelerate personalised cancer treatment by enabling clinicians to match therapies to individual patients better, Xinhua news agency reported. The study
